These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

536 related items for PubMed ID: 23416969

  • 1. The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics.
    Liu A, Feng B, Gu W, Cheng X, Tong T, Zhang H, Hu Y.
    Int J Oncol; 2013 Apr; 42(4):1399-407. PubMed ID: 23416969
    [Abstract] [Full Text] [Related]

  • 2. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.
    Feng BH, Liu AG, Gu WG, Deng L, Cheng XG, Tong TJ, Zhang HZ.
    Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735
    [Abstract] [Full Text] [Related]

  • 3. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
    Choijamts B, Jimi S, Kondo T, Naganuma Y, Matsumoto T, Kuroki M, Iwasaki H, Emoto M.
    Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
    [Abstract] [Full Text] [Related]

  • 4. Expression of CD133 in synovial sarcoma.
    Terry J, Nielsen T.
    Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):159-65. PubMed ID: 19752721
    [Abstract] [Full Text] [Related]

  • 5. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
    Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, Roz E, Caserini R, Lo Vullo S, Camerini T, Mariani L, Delia D, Calabrò E, Pastorino U, Sozzi G.
    Proc Natl Acad Sci U S A; 2009 Sep 22; 106(38):16281-6. PubMed ID: 19805294
    [Abstract] [Full Text] [Related]

  • 6. The ALDH1⁺ subpopulation of the human NMFH-1 cell line exhibits cancer stem-like characteristics.
    Li D, Zhang T, Gu W, Li P, Cheng X, Tong T, Wang W.
    Oncol Rep; 2015 May 22; 33(5):2291-8. PubMed ID: 25760144
    [Abstract] [Full Text] [Related]

  • 7. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.
    Ma L, Lai D, Liu T, Cheng W, Guo L.
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep 22; 42(9):593-602. PubMed ID: 20705681
    [Abstract] [Full Text] [Related]

  • 8. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma.
    Yang JP, Liu Y, Zhong W, Yu D, Wen LJ, Jin CS.
    Chin Med J (Engl); 2011 Apr 22; 124(7):1055-60. PubMed ID: 21542968
    [Abstract] [Full Text] [Related]

  • 9. An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinoma.
    Li M, Zhang L, Ge C, Chen L, Fang T, Li H, Tian H, Liu J, Chen T, Jiang G, Xie H, Cui Y, Yao M, Li J.
    Oncotarget; 2015 Sep 22; 6(28):25149-60. PubMed ID: 26327240
    [Abstract] [Full Text] [Related]

  • 10. Cancer stem-like cell behavior in anaplastic thyroid cancer: A challenging dilemma.
    Haghpanah V, Fallah P, Naderi M, Tavakoli R, Soleimani M, Larijani B.
    Life Sci; 2016 Feb 01; 146():34-9. PubMed ID: 26772823
    [Abstract] [Full Text] [Related]

  • 11. Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3.
    Guo R, Wu Q, Liu F, Wang Y.
    Oncol Rep; 2011 Jan 01; 25(1):141-6. PubMed ID: 21109969
    [Abstract] [Full Text] [Related]

  • 12. Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer.
    Jiang Y, He Y, Li H, Li HN, Zhang L, Hu W, Sun YM, Chen FL, Jin XM.
    Gastric Cancer; 2012 Oct 01; 15(4):440-50. PubMed ID: 22395309
    [Abstract] [Full Text] [Related]

  • 13. Identification and characterization of tumorigenic liver cancer stem/progenitor cells.
    Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, Zheng BJ, Guan XY.
    Gastroenterology; 2007 Jun 01; 132(7):2542-56. PubMed ID: 17570225
    [Abstract] [Full Text] [Related]

  • 14. Differential characteristics of CD133(+) and CD133 (-) Jurkat cells.
    Anbarlou A, Atashi A, Soleimani M, AkhavanRahnama M, Bohloli M, Mossahebi-Mohammadi M.
    In Vitro Cell Dev Biol Anim; 2015 Jun 01; 51(6):556-61. PubMed ID: 25630537
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma.
    Hang D, Dong HC, Ning T, Dong B, Hou DL, Xu WG.
    Dis Esophagus; 2012 Jun 01; 25(7):638-44. PubMed ID: 22236447
    [Abstract] [Full Text] [Related]

  • 16. Molecular characterization of CD133+ cancer stem-like cells in endometrial cancer.
    Nakamura M, Zhang X, Mizumoto Y, Maida Y, Bono Y, Takakura M, Kyo S.
    Int J Oncol; 2014 Mar 01; 44(3):669-77. PubMed ID: 24366104
    [Abstract] [Full Text] [Related]

  • 17. Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells.
    Jia Q, Zhang X, Deng T, Gao J.
    Cell Reprogram; 2013 Apr 01; 15(2):143-50. PubMed ID: 23438193
    [Abstract] [Full Text] [Related]

  • 18. Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery.
    Fang DD, Kim YJ, Lee CN, Aggarwal S, McKinnon K, Mesmer D, Norton J, Birse CE, He T, Ruben SM, Moore PA.
    Br J Cancer; 2010 Apr 13; 102(8):1265-75. PubMed ID: 20332776
    [Abstract] [Full Text] [Related]

  • 19. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
    Gambelli F, Sasdelli F, Manini I, Gambarana C, Oliveri G, Miracco C, Sorrentino V.
    Cell Biol Int; 2012 Jan 13; 36(1):29-38. PubMed ID: 21916848
    [Abstract] [Full Text] [Related]

  • 20. In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line.
    Wei XD, Zhou L, Cheng L, Tian J, Jiang JJ, Maccallum J.
    Head Neck; 2009 Jan 13; 31(1):94-101. PubMed ID: 18853445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.